Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series

Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series

Xin He,1,2 Dongyue Yang,1,2 Lingyao Lai,1,2 Jing Lang,1,2 Kebo Wei,1,2 Min Xiao1 1Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People’s Republic of China; 2School of Clinical Medicine, Chengdu University of Traditional Chinese...

Bibliografski detalji
Glavni autori:	He X, Yang D, Lai L, Lang J, Wei K, Xiao M
Format:	Članak
Jezik:	English
Izdano:	Dove Medical Press 2024-03-01
Serija:	Clinical, Cosmetic and Investigational Dermatology
Teme:	upadacitinib alopecia areata jak inhibitors jak-stat
Online pristup:	https://www.dovepress.com/upadacitinib-for-alopecia-areata-in-different-backgrounds-a-case-serie-peer-reviewed-fulltext-article-CCID

Slični predmeti

Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
od: Ieva Lingytė, i dr.
Izdano: (2024-09-01)

Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
od: C. Perricone, i dr.
Izdano: (2024-10-01)

Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
od: Sofia Faria, i dr.
Izdano: (2023-09-01)

Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
od: Xingqi ZHANG
Izdano: (2022-04-01)

Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
od: Mu Y, i dr.
Izdano: (2024-08-01)

Modern Management Approaches for Alopecia Areata
od: Eduard T. Ambarchyan, i dr.
Izdano: (2024-12-01)

The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
od: Tomasz Skrzypczak, i dr.
Izdano: (2024-11-01)

Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
od: Siddhi B. Chikhalkar, i dr.
Izdano: (2024-06-01)

Survey of pediatric dermatologist views on treatment for alopecia areata
od: David Bitterman, BA, i dr.
Izdano: (2023-12-01)

Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
od: Mara Giavina-Bianchi, MD, PhD, i dr.
Izdano: (2024-08-01)

Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
od: Matteini E, i dr.
Izdano: (2024-10-01)

Alopecia areata: from pathophysiology to therapeutic innovation
od: Nuno Lourenço, i dr.
Izdano: (2023-04-01)

Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
od: Olivia Katamanin, BS, i dr.
Izdano: (2024-01-01)

Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
od: Jundong Huang, i dr.
Izdano: (2023-11-01)

Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
od: Sihan Wang, i dr.
Izdano: (2025-01-01)

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
od: Sarah Choe, i dr.
Izdano: (2024-01-01)

Inhibition of T-cell activity in alopecia areata: recent developments and new directions
od: Thierry Passeron, i dr.
Izdano: (2023-11-01)

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
od: Carlo A. Vignoli, i dr.
Izdano: (2025-12-01)

A Threefold Association Between Vitiligo and Alopecia Areata: Results from a Nationwide Case-control Observational Study
od: Yonit Wohl, i dr.
Izdano: (2025-02-01)

The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
od: Mei-qi Mao, i dr.
Izdano: (2023-06-01)

Upadacitinib for the management of bullous pemphigoid coexisting with psoriasis vulgaris: a case report and literature review
od: Fangying Su, i dr.
Izdano: (2024-12-01)

Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
od: Lucia Peterle, i dr.
Izdano: (2023-01-01)

Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
od: Alfred Ammoury, i dr.
Izdano: (2023-06-01)

Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
od: Daciana Elena Brănișteanu, i dr.
Izdano: (2025-02-01)

Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
od: Axel De Greef, i dr.
Izdano: (2023-09-01)

Gut microbiome, metabolome and alopecia areata
od: Zhiyu Liu, i dr.
Izdano: (2023-11-01)

Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
od: Kabir Sardana, i dr.
Izdano: (2023-01-01)

Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
od: Ting Yan, i dr.
Izdano: (2024-04-01)

Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
od: Jennifer Fu, i dr.
Izdano: (2024-09-01)

Upadacitinib in nail psoriasis: a case report
od: Na Wang, i dr.
Izdano: (2023-12-01)

The progress of rheumatology in the 21st century potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases
od: E. L. Nasonov, i dr.
Izdano: (2020-11-01)

Response to upadacitinib monotherapy in a patient with eczematid-like pigmented purpuric dermatosis
od: Aditi Chokshi, DO, i dr.
Izdano: (2025-02-01)

Successful Treatment of Disseminated Granuloma Annulare with Upadacitinib
od: Axel De Greef, i dr.
Izdano: (2024-03-01)

Refractory Hailey–Hailey disease cleared with upadacitinib
od: Lauren Murphy, BS, i dr.
Izdano: (2023-11-01)

Upadacitinib for prurigo nodularis
od: Clara Muntaner-Virgili, MD, i dr.
Izdano: (2024-06-01)

A case of erythema annulare centrifugum cleared with upadacitinib
od: Valerie Foy, DO, i dr.
Izdano: (2023-12-01)

Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
od: Natasha Atanaskova Mesinkovska, i dr.
Izdano: (2024-06-01)

Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
od: Yuliya Lytvyn, i dr.
Izdano: (2022-11-01)

Treatment of rosacea with upadacitinib and abrocitinib: case report and review of evidence for Janus kinase inhibition in rosacea
od: Ting Zhang, i dr.
Izdano: (2024-07-01)

Amenorrhea in an Adolescent Female as a Rare Adverse Event of Upadacitinib Treatment for Atopic Dermatitis
od: Teng Y, i dr.
Izdano: (2024-11-01)